Page last updated: 2024-09-04

mk 767 and muraglitazar

mk 767 has been researched along with muraglitazar in 2 studies

Compound Research Comparison

Studies
(mk 767)
Trials
(mk 767)
Recent Studies (post-2010)
(mk 767)
Studies
(muraglitazar)
Trials
(muraglitazar)
Recent Studies (post-2010) (muraglitazar)
32010851025

Protein Interaction Comparison

ProteinTaxonomymk 767 (IC50)muraglitazar (IC50)
Peroxisome proliferator-activated receptor gammaHomo sapiens (human)0.1867
Peroxisome proliferator-activated receptor alphaHomo sapiens (human)0.22

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Henke, BR1
Kagechika, K; Kubo, H; Shibata, Y; Usui, H; Yamaguchi, M1

Reviews

1 review(s) available for mk 767 and muraglitazar

ArticleYear
Peroxisome proliferator-activated receptor alpha/gamma dual agonists for the treatment of type 2 diabetes.
    Journal of medicinal chemistry, 2004, Aug-12, Volume: 47, Issue:17

    Topics: Animals; Diabetes Mellitus, Type 2; Humans; Hyperglycemia; Hypoglycemic Agents; Models, Molecular; Molecular Structure; Receptors, Cytoplasmic and Nuclear; Transcription Factors

2004

Other Studies

1 other study(ies) available for mk 767 and muraglitazar

ArticleYear
Design, synthesis and evaluation of novel zwitterionic compounds as PPARα/γ dual agonists (1).
    Bioorganic & medicinal chemistry letters, 2012, Dec-01, Volume: 22, Issue:23

    Topics: Animals; Blood Glucose; Drug Design; Mice; PPAR alpha; PPAR gamma; Structure-Activity Relationship; Thiazolidinediones; Triglycerides; Weight Gain

2012